Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,432.00
Bid: 1,431.00
Ask: 1,434.00
Change: 33.00 (2.36%)
Spread: 3.00 (0.21%)
Open: 1,417.00
High: 1,435.00
Low: 1,415.00
Prev. Close: 1,399.00
SMSN Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sales of Stakes (Update)

30 Apr 2015 09:38

RNS Number : 8216L
Samsung Electronics Co. Ld
30 April 2015
 



Sales of Stakes (Update)

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") announced today that the sales of SEC's stake in Samsung General Chemicals Co., LTD. to Hanwha Chemical Corporation (KS009830) and Hanwha Energy Corporation has been finalized and closed on April 30, 2015. The

deal was originally announced on November 26, 2014, following the approval of the transaction by

SEC's Board of Directors earlier in the day. The information below sets forth updates to the

transaction details as of the closing.

 

Details

1. Details of Transaction:

Number of Shares Outstanding and Number of Shares to be Sold (per November 26, 2014, disclosure):

Samsung Electronics plans to sell a total of 3,016,705 shares.

* Total number of Samsung General Chemicals shares outstanding: 57,060,923 (as of November 26, 2014)

 

Updated Information:

Samsung Electronics has sold a total of 3,016,705 shares.

* Total number of Samsung General Chemicals shares outstanding: 55,471,383 (as of the April 30, 2015)

(※ The change in the number of shares outstanding reflects the cancelation of treasury shares of Samsung

General Chemicals prior to closing.)

 

2. Transaction Amount (Total Consideration): 

Original Transaction Amount: KRW 100 billion

Updated Transaction Amount: KRW 97 billion

Updated transaction amount reflects the adjustment to the purchase price made following due diligence as per the terms of the definitive agreement.

† The purchase price is subject to upward adjustment subject to the satisfaction of certain conditions.

 

3. Reason for Divestment

The purpose of divestment is to reinvest the capital in new businesses and in SEC's existing to strengthen the

company's core competencies.

 

4. Other Information

ž Details on contract resolution (including put-option): None

 

* This public disclosure is in accordance with the Financial Investment Services and Capital Markets Act (Article 391) of

the Republic of Korea, which requires major shareholders of a stock-listed corporation to report matters concerning the

current status of specific securities, etc. owned by type and changes therein. This disclosure contains forward-looking

statements. Readers are cautioned that such forward-looking statements involve risks and uncertainties that could

significantly affect actual results from those expressed in any such forward-looking statements due to, without limitation, (i) general economic conditions, including in particular economic conditions in SEC's core businesses and core markets,

(ii) performance of financial markets, including emerging markets, and including market volatility, liquidity and credit

events, (iii) currency exchange rates, (iv) changing levels of competition, (v) changes in laws and regulations, (vi) general competitive factors, in each case on a local, regional, national and/or global basis. The matters discussed herein may also

be affected by risks and uncertainties described from time to time in SEC's filings with the Korea Stock Exchange (KRX), FSS (Korea) and Samsung Website. Further information about risks and uncertainties affecting Samsung Electronics Co., Ltd. is included throughout our most recent annual and interim reports, as well as our most recent earnings release, which are available on http://www.samsung.com/ir. Should one or more of these risks or uncertainties materialize, or should

underlying assumptions prove incorrect, actual results, performance or achievements of SEC may vary materially from

those described in the relevant forward-looking statement, and all such statements are subject to certain risks and

uncertainties that could cause our actual results to be materially different from those expressed herein. The company

assumes no obligation to update any forward-looking statement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISSDMSASFISEDL
Date   Source Headline
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report
27th Jul 20238:15 amRNSTransaction with Affiliate Company
27th Jul 20238:09 amRNSCharitable Contribution
27th Jul 20238:04 amRNSQuarterly Dividend for Second Quarter 2023
27th Jul 20238:03 amRNS2023 2Q Earning Release
7th Jul 20237:31 amRNS2Q 2023 Pre-Earnings Guidance
3rd Jul 202310:12 amRNSSustainability Report 2023
31st May 202310:15 amRNSCorporate Governance Report FY2022
31st May 20239:26 amRNSCorporate Governance Report FY2022
31st May 20239:22 amRNS2023 1Q Interim Business Report
28th Apr 20237:47 amRNS2022 Business Report
27th Apr 20238:09 amRNSCharitable Contribution
27th Apr 20238:07 amRNSQuarterly Dividend for First Quarter 2023
27th Apr 20238:05 amRNS2023 1Q Earning Release
13th Apr 20238:33 amRNSNotice of 1Q 2023 Earning Release
11th Apr 20237:00 amRNS1Q 2023 Pre-Earnings Guidance
15th Mar 202310:30 amRNSResults of the 54th Annual General Meeting
16th Feb 20237:49 amRNS2022 Separate Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.